Literature DB >> 23661325

Nicotine from edible Solanaceae and risk of Parkinson disease.

Susan Searles Nielsen1, Gary M Franklin, W T Longstreth, Phillip D Swanson, Harvey Checkoway.   

Abstract

OBJECTIVE: To test whether risk of Parkinson disease (PD) is associated with consumption of nicotine-containing edibles from the same botanical family as tobacco, Solanaceae, including peppers, tomatoes, and potatoes.
METHODS: In a population-based study with 490 newly diagnosed idiopathic PD cases diagnosed during 1992-2008 at the University of Washington Neurology Clinic or Group Health Cooperative in western Washington State and 644 unrelated, neurologically normal controls, we examined whether PD was associated with self-reported typical frequency of consumption of peppers, tomatoes, tomato juice, and potatoes during adulthood, while adjusting for consumption of other vegetables, age, sex, race/ethnicity, tobacco use, and caffeine.
RESULTS: PD was inversely associated with consumption of all edible Solanaceae combined (relative risk [RR] = 0.81, 95% confidence interval [CI] = 0.65-1.01 per time per day), but not consumption of all other vegetables combined (RR = 1.00, 95% CI = 0.92-1.10). The trend strengthened when we weighted edible Solanaceae by nicotine concentration (ptrend = 0.004). An inverse association was also evident for peppers specifically (ptrend = 0.005). The potentially protective effect of edible Solanaceae largely occurred in men and women who had never used tobacco or who had smoked cigarettes < 10 years.
INTERPRETATION: Dietary nicotine or other constituents of tobacco and peppers may reduce PD risk. However, confirmation and extension of these findings are needed to strengthen causal inferences that could suggest possible dietary or pharmaceutical interventions for PD prevention.
Copyright © 2013 American Neurological Association.

Entities:  

Mesh:

Year:  2013        PMID: 23661325      PMCID: PMC4864980          DOI: 10.1002/ana.23884

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  27 in total

1.  Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.

Authors:  Daniel Paris; David Beaulieu-Abdelahad; Corbin Bachmeier; Jon Reed; Ghania Ait-Ghezala; Alex Bishop; Jin Chao; Venkat Mathura; Fiona Crawford; Michael Mullan
Journal:  Eur J Pharmacol       Date:  2011-09-19       Impact factor: 4.432

2.  Passive smoking and Parkinson disease.

Authors:  George D Mellick; Coral E Gartner; Peter A Silburn; Diana Battistutta
Journal:  Neurology       Date:  2006-07-11       Impact factor: 9.910

3.  A longitudinal evaluation of fruit and vegetable consumption and cigarette smoking.

Authors:  Jeffrey P Haibach; Gregory G Homish; Gary A Giovino
Journal:  Nicotine Tob Res       Date:  2012-05-21       Impact factor: 4.244

4.  Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models.

Authors:  Hiroki Takeuchi; Takashi Yanagida; Masatoshi Inden; Kazuyuki Takata; Yoshihisa Kitamura; Kentaro Yamakawa; Hideyuki Sawada; Yasuhiko Izumi; Noriyuki Yamamoto; Takeshi Kihara; Kengo Uemura; Haruhisa Inoue; Takashi Taniguchi; Akinori Akaike; Ryosuke Takahashi; Shun Shimohama
Journal:  J Neurosci Res       Date:  2009-02       Impact factor: 4.164

5.  Anatabine ameliorates experimental autoimmune thyroiditis.

Authors:  Patrizio Caturegli; Alessandra De Remigis; Marcella Ferlito; Melissa A Landek-Salgado; Shintaro Iwama; Shey-Cherng Tzou; Paul W Ladenson
Journal:  Endocrinology       Date:  2012-07-17       Impact factor: 4.736

6.  Transient receptor potential vanilloid subtype 1 mediates cell death of mesencephalic dopaminergic neurons in vivo and in vitro.

Authors:  Sang R Kim; Da Y Lee; Eun S Chung; Uh T Oh; Seung U Kim; Byung K Jin
Journal:  J Neurosci       Date:  2005-01-19       Impact factor: 6.167

7.  Environmental tobacco smoke and Parkinson's disease.

Authors:  Susan Searles Nielsen; Lisa G Gallagher; Jessica I Lundin; W T Longstreth; Terri Smith-Weller; Gary M Franklin; Phillip D Swanson; Harvey Checkoway
Journal:  Mov Disord       Date:  2011-11-16       Impact factor: 10.338

8.  Prospective study of dietary pattern and risk of Parkinson disease.

Authors:  Xiang Gao; Honglei Chen; Teresa T Fung; Giancarlo Logroscino; Michael A Schwarzschild; Frank B Hu; Alberto Ascherio
Journal:  Am J Clin Nutr       Date:  2007-11       Impact factor: 7.045

9.  Diet and Parkinson's disease. I: A possible role for the past intake of specific foods and food groups. Results from a self-administered food-frequency questionnaire in a case-control study.

Authors:  W Hellenbrand; A Seidler; H Boeing; B P Robra; P Vieregge; P Nischan; J Joerg; W H Oertel; E Schneider; G Ulm
Journal:  Neurology       Date:  1996-09       Impact factor: 9.910

10.  α7 nicotinic acetylcholine receptor-mediated neuroprotection against dopaminergic neuron loss in an MPTP mouse model via inhibition of astrocyte activation.

Authors:  Yuan Liu; Jun Hu; Jie Wu; Chenlei Zhu; Yujian Hui; Yaping Han; Zuhu Huang; Kevin Ellsworth; Weimin Fan
Journal:  J Neuroinflammation       Date:  2012-05-24       Impact factor: 8.322

View more
  17 in total

Review 1.  Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical significance.

Authors:  R Anne Stetler; Rehana K Leak; Yu Gan; Peiying Li; Feng Zhang; Xiaoming Hu; Zheng Jing; Jun Chen; Michael J Zigmond; Yanqin Gao
Journal:  Prog Neurobiol       Date:  2014-01-02       Impact factor: 11.685

Review 2.  Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review.

Authors:  Konstantinos E Farsalinos; Riccardo Polosa
Journal:  Ther Adv Drug Saf       Date:  2014-04

Review 3.  Gene-by-environment interactions in Alzheimer's disease and Parkinson's disease.

Authors:  Amy R Dunn; Kristen M S O'Connell; Catherine C Kaczorowski
Journal:  Neurosci Biobehav Rev       Date:  2019-06-14       Impact factor: 8.989

Review 4.  Clinical trials in REM sleep behavioural disorder: challenges and opportunities.

Authors:  Aleksandar Videnovic; Yo-El S Ju; Isabelle Arnulf; Valérie Cochen-De Cock; Birgit Högl; Dieter Kunz; Federica Provini; Pietro-Luca Ratti; Mya C Schiess; Carlos H Schenck; Claudia Trenkwalder
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-05-13       Impact factor: 10.154

5.  Dietary nicotine intake and risk of Parkinson disease: a prospective study.

Authors:  Chaoran Ma; Samantha Molsberry; Yanping Li; Michael Schwarzschild; Alberto Ascherio; Xiang Gao
Journal:  Am J Clin Nutr       Date:  2020-10-01       Impact factor: 7.045

6.  A novel (S)-6-hydroxynicotine oxidase gene from Shinella sp. strain HZN7.

Authors:  Jiguo Qiu; Yin Wei; Yun Ma; Rongti Wen; Yuezhong Wen; Weiping Liu
Journal:  Appl Environ Microbiol       Date:  2014-07-07       Impact factor: 4.792

7.  Traumatic brain injury in the prodromal period of Parkinson's disease: A large epidemiological study using medicare data.

Authors:  Alejandra Camacho-Soto; Mark N Warden; Susan Searles Nielsen; Amber Salter; David L Brody; Heidi Prather; Brad A Racette
Journal:  Ann Neurol       Date:  2017-10-31       Impact factor: 10.422

Review 8.  The emerging role of nutrition in Parkinson's disease.

Authors:  Stacey E Seidl; Jose A Santiago; Hope Bilyk; Judith A Potashkin
Journal:  Front Aging Neurosci       Date:  2014-03-07       Impact factor: 5.750

9.  Use of medical care biases associations between Parkinson disease and other medical conditions.

Authors:  Anat Gross; Brad A Racette; Alejandra Camacho-Soto; Umber Dube; Susan Searles Nielsen
Journal:  Neurology       Date:  2018-05-09       Impact factor: 9.910

Review 10.  Epidemiology of Parkinson's Disease-East Versus West.

Authors:  Masoom M Abbas; Zheyu Xu; Louis C S Tan
Journal:  Mov Disord Clin Pract       Date:  2017-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.